Now, by analyzing thousands of proteins found in the blood, scientists at the University of California, San Francisco (UCSF), have created what they view as the clearest picture yet of when the ...
MS patients have increased risks of developing other autoimmune diseases, necessitating careful treatment planning to balance efficacy and risk. Dimethyl fumarate, anti-CD20 antibodies, and ozanimod ...
Medical experts use the term “cerebellar ataxia” when referring to conditions that lead to a lack of muscle control. Dysmetria is one form of cerebellar ataxia. Dysmetria occurs due to the improper ...
A CONCERNING increase in the incidence of central nervous system (CNS) demyelination among patients undergoing biologic treatments for rheumatologic diseases has been revealed by a new study. The ...
A dad was diagnosed with ALS – a fatal disease that attacks the brain and spinal cord – after a twitch in his arm turned out to be more than a pinched nerve. Andres, 41, from Florida, was told he had ...
LOS ANGELES, May 21, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, ...
A team led by University of Pittsburgh School of Public Health geneticists has shown, for the first time, that a gene "silencer" that resides in junk DNA is directly sparing people from a devastating ...
Hereditary Central Nervous System Demyelinating Diseases Market Outlook 2025-2035: The 7 major hereditary central nervous system demyelinating diseases market are expected to exhibit a CAGR of 9.71% ...
A comprehensive meta-analysis of 18 studies, involving more than 1 million patients with autoimmune diseases, has revealed a 36% higher risk of central nervous system (CNS) inflammatory diseases in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback